Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation

• Autori principali: N. A. Novikova (Autore), A. N. Volovchenko (Autore)
• Natura: Libro
• Pubblicazione: Столичная издательская компания, 2016-11-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Atrial fibrillation (AF) is the most common cardiac cause of systemic embolism and cardioembolic stroke. The risk of thromboembolic complications increases significantly when performing for electrical cardioversion. Vitamin K antagonists (warfarin) more often used to prepare for electrical cardiover...